Oss, Netherlands

Lars Anders Van Der Veen



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars Anders Van Der Veen: Innovator in Pharmaceutical Chemistry

Introduction

Lars Anders Van Der Veen is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can aid in the treatment of infertility. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Lars holds a patent for his invention titled "(Dihydro)pyrrolo[2,1-α]isoquinolines." This patent relates to 5,6-dihydropyrrolo[2,1-α]isoquinoline and pyrrolo[2,1-α]isoquinoline derivatives, which are described by a general formula (I) or a pharmaceutically acceptable salt thereof. The compounds developed through this research have potential applications in treating infertility, highlighting the importance of his work in addressing significant health issues.

Career Highlights

Lars is currently employed at MSD Oss B.V., where he continues to engage in innovative research and development. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing the impact of his work on pharmaceutical advancements.

Collaborations

Lars has had the opportunity to work alongside esteemed colleagues such as Rachel Deborah Van Rijn and Hubert Jan Josef Loozen. These collaborations have likely contributed to the success of his projects and the overall progress in their shared field of expertise.

Conclusion

Lars Anders Van Der Veen is a distinguished inventor whose work in pharmaceutical chemistry is making a difference in the treatment of infertility. His patent and ongoing research at MSD Oss B.V. reflect his commitment to innovation and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…